About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

12 Med. L. Int'l 3 (2012)

handle is hein.journals/medclint12 and id is 1 raw text is: 




                                                          MEDICAL LAW
Editorial                                                INTERNATIONAL

                                                             Medical Law International
                                                                       12(I) 3-10
Com      m   ercialization                                     K The Author(s) 2012
                                                              Reprints and permission:
versus       open      science                       sagepub.co.uk/journalsPermissions.nav
               u   o e sDOI: 10.1177/0968533212441887
                                                                   mli sagepub corn
Making sense of the                                                miSAGE
                                                                    OSAGE
message(s) in the bottle




Shawn HE Harmon
University of Edinburgh, UK


Timothy Caulfield
University of Alberta, Canada


Yann Joly
McGill University, Canada



Abstract
Efforts to improve research outcomes have resulted in genomic researchers being
confronted with complex and seemingly contradictory instructions about how to per-
form their tasks. For example, increasing pressure to commercialise (academic) research
is paralleled by pressure to collaborate, share data, and disseminate knowledge quickly
so as to encourage scientific progress, maximise research impact, and meet humanitarian
goals. This article briefly explores some of the relevant instructions in Canada and the
United Kingdom and concludes that commercialisation and more open collaborative
practices are not necessarily irreconcilable. They should be viewed as complementary
elements of an innovation framework for which more evidence must be gathered with
respect to the impact of this coexistence.


Keywords
open science, data sharing, commercialisation, translation, technology transfer, stem cell,
genome, academic research, innovation, genomics research



Corresponding author:
Timothy Caulfield, Health Law and Science Policy Group, Law Centre, University of Alberta, Edmonton, AB,
T6G 2H5, UK
Email: tcaulfld@law.ualberta.ca

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most